GO
Loading...

Allergan Inc

More

  • Final Glance: Medical Devices companies Friday, 31 Oct 2014 | 6:04 PM ET

    Allergan rose$. 62 or. 3 percent, to $190.06. Baxter International Inc. rose$. 08 or. 1 percent, to $70.14. Boston Scientific Corp. rose$. 10 or. 8 percent, to $13.28.

  • Midday Glance: Medical Devices companies Friday, 31 Oct 2014 | 2:49 PM ET

    Allergan rose $1.55 or. 8 percent, to $190.99. Baxter International Inc. rose$. 22 or. 3 percent, to $70.28. Boston Scientific Corp. rose$. 14 or 1.0 percent, to $13.32.

  • Early Glance: Medical Devices companies Friday, 31 Oct 2014 | 12:28 PM ET

    Allergan rose$. 43 or. 2 percent, to $189.87. Johnson& Johnson rose$. 82 or. 8 percent, to $107.86. Medtronic rose$. 82 or 1.2 percent, to $68.25.

  • Final Glance: Medical Devices companies Thursday, 30 Oct 2014 | 6:02 PM ET

    Allergan rose $2.67 or 1.4 percent, to $189.44. Baxter International Inc. fell$. 35 or. 5 percent, to $70.06. Boston Scientific Corp. rose$. 04 or. 3 percent, to $13.18.

  • Midday Glance: Medical Devices companies Thursday, 30 Oct 2014 | 1:17 PM ET

    Allergan rose $1.73 or. 9 percent, to $188.50. Baxter International Inc. fell$. 79 or 1.1 percent, to $69.62. Boston Scientific Corp. rose$. 06 or. 4 percent, to $13.20.

  • Early Glance: Medical Devices companies Thursday, 30 Oct 2014 | 11:28 AM ET

    Allergan fell$. 49 or. 3 percent, to $186.28. Baxter International Inc. fell$. 49 or. 7 percent, to $69.92. Boston Scientific Corp. fell$. 07 or. 5 percent, to $13.07.

  • Final Glance: Medical Devices companies Wednesday, 29 Oct 2014 | 6:02 PM ET

    Allergan rose $4.17 or 2.3 percent, to $186.77. Baxter International Inc. rose$. 09 or. 1 percent, to $70.41. Boston Scientific Corp. fell$. 07 or. 5 percent, to $13.14.

  • Midday Glance: Medical Devices companies Wednesday, 29 Oct 2014 | 1:41 PM ET

    Allergan rose $4.73 or 2.6 percent, to $187.33. Baxter International Inc. rose$. 01 or percent, to $70.33. Boston Scientific Corp. rose$. 01 or percent, to $13.22.

  • Early Glance: Medical Devices companies Wednesday, 29 Oct 2014 | 10:53 AM ET

    Allergan rose $3.15 or 1.7 percent, to $185.75. Baxter International Inc. rose$. 16 or. 2 percent, to $70.48. Boston Scientific Corp. rose$. 08 or. 6 percent, to $13.29.

  • Final Glance: Medical Devices companies Tuesday, 28 Oct 2014 | 6:14 PM ET

    Allergan rose$. 27 or. 1 percent, to $182.60. Baxter International Inc. rose$. 47 or. 7 percent, to $70.32. Boston Scientific Corp. rose$. 11 or. 8 percent, to $13.21.

  • Midday Glance: Medical Devices companies Tuesday, 28 Oct 2014 | 1:25 PM ET

    Allergan fell$. 37 or. 2 percent, to $181.96. Baxter International Inc. rose$. 01 or percent, to $69.86. Boston Scientific Corp. rose$. 04 or. 3 percent, to $13.14.

  • Early Glance: Medical Devices companies Tuesday, 28 Oct 2014 | 10:31 AM ET

    Allergan fell$. 51 or. 3 percent, to $181.82. Boston Scientific Corp. rose$. 04 or. 3 percent, to $13.14. Medtronic rose$. 04 or. 1 percent, to $66.30.

  • Final Glance: Medical Devices companies Monday, 27 Oct 2014 | 6:06 PM ET

    Allergan fell $1.88 or 1.0 percent, to $182.33. Baxter International Inc. rose$. 02 or percent, to $69.85. Boston Scientific Corp. rose$. 11 or. 8 percent, to $13.10.

  • Midday Glance: Medical Devices companies Monday, 27 Oct 2014 | 1:17 PM ET

    Allergan fell$. 96 or. 5 percent, to $183.25. Baxter International Inc. fell$. 02 or percent, to $69.81. Boston Scientific Corp. rose$. 13 or 1.0 percent, to $13.12.

  • Early Glance: Medical Devices companies Monday, 27 Oct 2014 | 10:40 AM ET

    Allergan fell$. 40 or. 2 percent, to $183.81. Medtronic fell$. 19 or. 3 percent, to $66.37. St. Jude Medical Inc. fell$. 19 or. 3 percent, to $60.28.

  • BUSINESS-NEWS-SCHEDULE AT 1330 GMT /9.30 AM ET Monday, 27 Oct 2014 | 10:08 AM ET

    MILAN- Italy's Monte dei Paschi di Siena is likely to try to plug a capital shortfall uncovered by Europe- wide stress tests through asset sales and possibly another cash call, but longer term a takeover could be inevitable. LONDON- Europe's banking healthcheck showed countries and lenders are implementing global capital rules at vastly different speeds, and...

  • Allergan CEO on the call     Monday, 27 Oct 2014 | 9:38 AM ET

    CNBC's David Faber reports on comments made by Allergan chairman and CEO David E.I. Pyott on the process of a potential acquisition.

  • Oct 27- Valeant Pharmaceuticals International Inc said it was prepared to raise its cash-and-stock offer for Allergan Inc to at least $200 per share. An offer of $200 per share offer would value Allergan at $59.44 billion. Valeant CEO Michael Pearson said in a letter to Allergan's board that Allergan's stock would not be trading at the multiples it is now if it...

  • Early Movers: MRK, AGN, BABA, TSLA, F & more Monday, 27 Oct 2014 | 8:01 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Valeant: We'll bump Allergan offer to $200 a share Monday, 27 Oct 2014 | 7:28 AM ET

    The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12 percent, which would mean $200 or more per share for the maker of Botox. The letter to Allergan's board Monday did not break down the exact terms of the new offer, but Valeant said the increase would consist of added "consideration" and expected appreciation...